Please ensure Javascript is enabled for purposes of website accessibility

Chamath Palihapitiya's Clover Health Is Suddenly a Meme Stock

By Danny Vena - Jun 8, 2021 at 2:08PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares more than doubled at one point Tuesday on growing interest from retail investors who view it the company a short squeeze candidate.

Clover Health Investments (CLOV 4.29%) stock surged by as much as 104% on Tuesday after the company attracted the attention of the WallStreetBets subreddit as its next short squeeze candidate. The Chamath Palihapitiya-backed Medicare insurance technologist went public in January via a $3.7 billion merger with a special purpose acquisition company. As of 2 p.m. EDT, it was trading roughly 76% higher for the session. 

The WallStreetBets investor forum, which focuses on stocks it believes are undervalued or have been unfairly targeted by short-sellers, now has more than 10 million participants, and it has been instrumental in creating "meme stocks" in recent months. Some of these have rallied to dizzying heights after hordes of retail investors piled into them in hopes of driving out and punishing the short-sellers. 

Space rocket flies through a layer of clouds.

Image source: Getty Images.

When an investor believes a stock's price will decline, they can borrow shares of the stock in question, then immediately resell them to another buyer. If the stock price subsequently falls, the short-seller can then buy back shares at the lower price, return the borrowed shares, and immediately make a profit. On the other hand, if the stock rises, the short-seller will eventually have to buy back those shares at a higher price, and the trade will cost them money.

Clover Health's stock price has been under pressure in recent weeks after Hindenburg Research levied a short attack against the company. The short-seller charged, among other things, that the backers had misled investors into buying a company with a broken business model. The report also alleged that Clover Health was currently under investigation by the U.S. Department of Justice, something it failed to divulge to investors. 

The percentage of Clover Health shares currently held short recently stood at 43.5%, making it an ideal candidate for a short squeeze. Roughly halfway through the trading day Tuesday, over 400 million shares of Clover Health had changed hands, 18 times greater than its 30-day average of 22 million shares. 

Danny Vena has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Clover Health Investments. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Clover Health Investments, Corp. Stock Quote
Clover Health Investments, Corp.
CLOV
$3.40 (4.29%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/08/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.